Predictors of Death for Hospitalized Patients with COVID-19 in the First Year of the Pandemic in Northern Brazil - A Retrospective Study

Daniele Melo Sardinha *

Post-Graduate Program in Epidemiology and Health Surveillance, Instituto Evandro Chagas (PPGEVS/IEC), Ananindeua, Pará, Brazil and Post-Graduate Program in Parasitic Biology in the Amazon, State University of Pará, Evandro Chagas Institute (PPGBPA/UEPA/IEC), Ananindeua, Pará, Brazil.

Yan Corrêa Rodrigues

Post-Graduate Program in Parasitic Biology in the Amazon, State University of Pará, Evandro Chagas Institute (PPGBPA/UEPA/IEC), Ananindeua, Pará, Brazil.

Ana Lúcia da Silva Ferreira

Post-Graduate Program in Parasitic Biology in the Amazon, State University of Pará, Evandro Chagas Institute (PPGBPA/UEPA/IEC), Ananindeua, Pará, Brazil.

Karla Valéria Batista Lima

Post-Graduate Program in Parasitic Biology in the Amazon, State University of Pará, Evandro Chagas Institute (PPGBPA/UEPA/IEC), Ananindeua, Pará, Brazil.

Ricardo José de Paula Souza e Guimarães

Post-Graduate Program in Epidemiology and Health Surveillance, Instituto Evandro Chagas (PPGEVS/IEC), Ananindeua, Pará, Brazil and Post-Graduate Program in Parasitic Biology in the Amazon, State University of Pará, Evandro Chagas Institute (PPGBPA/UEPA/IEC), Ananindeua, Pará, Brazil and Geoprocessing Laboratory of the Instituto Evandro Chagas (LABGEO/IEC), Ananindeua, Pará, Brazil.

Luana Nepomuceno Gondim Costa Lima

Post-Graduate Program in Epidemiology and Health Surveillance, Instituto Evandro Chagas (PPGEVS/IEC), Ananindeua, Pará, Brazil and Post-Graduate Program in Parasitic Biology in the Amazon, State University of Pará, Evandro Chagas Institute (PPGBPA/UEPA/IEC), Ananindeua, Pará, Brazil.

*Author to whom correspondence should be addressed.


Abstract

Objective: Identified predictors of death for hospitalized patients with COVID-19 in the First Year of the Pandemic in Northern Brazil.

Methods: A longitudinal retrospective cohort study was carried out, using data from the Brazilian Ministry of Health's COVID-19 severe case and hospitalization notification forms, considering the period from January 1, 2020 to December 31, 2020. The extracted variables were related to the epidemiological profile and outcome of the disease. Data were analyzed using SPSS software, with chi-square test by contingency table, binary logistic regression, and survival analysis.

Results: Those vaccinated against influenza were associated with survivors in univariate and multivariate analysis, as well as survival analysis. The predictors of lethality were invasive ventilation (OR 6.627; CI 5.780–7.597), other pneumopathy (OR 1.901; CI 1.439–2.510), dyspnea (OR 1.899; CI 1.737–2.076), immunodeficiency (OR 1.905; CI 1.493–2.431), hospitalized in ICU (OR 1.764; CI 1.588–1.959), chronic kidney disease (OR 1.753; CI 1.396–2.203), diabetes mellitus (OR 1.210; CI 1.108–1.321), and male sex (OR 1.198; CI 1.111–1.293).

Conclusion: Those vaccinated against influenza were associated with survival; namely, they showed a lower risk of death in the regression and showed longer survival in the survival analysis, when compared to those who were not vaccinated. The lethality was higher than the other studies, while the predictors were similar. Evidencing that COVID-19 had more impact on deaths, which may be associated with the vulnerability factors of the region.

Keywords: Severe acute respiratory syndrome, Brazil, pandemic, COVID-19, SARS-CoV-2


How to Cite

Sardinha , Daniele Melo, Yan Corrêa Rodrigues, Ana Lúcia da Silva Ferreira, Karla Valéria Batista Lima, Ricardo José de Paula Souza e Guimarães, and Luana Nepomuceno Gondim Costa Lima. 2023. “Predictors of Death for Hospitalized Patients With COVID-19 in the First Year of the Pandemic in Northern Brazil - A Retrospective Study”. Archives of Current Research International 23 (5):17-33. https://doi.org/10.9734/acri/2023/v23i5572.

Downloads

Download data is not yet available.

References

McIntosh K, Perlman S. Coronaviruses, including Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). Mand. Douglas, Bennett’s Princ. Pract. Infect. Dis. Elsevier Inc. 2014;2:1928-1936. Available:https://doi.org/10.1016/B978-1-4557-4801-3.00157-0

Cunha CB, Opal SM. Middle East Respiratory Syndrome (MERS). Virulence. 2014;5:650–4. Available:https://doi.org/10.4161/viru.32077

Eckerle I, Müller MA, Kallies S, Gotthardt DN, Drosten C. In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) coronavirus infection. Virol J. 2013;10:359. Available:https://doi.org/10.1186/1743-422X-10-359

Hui DSC, Zumla A. Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features. Infect Dis Clin North Am 2019;33:869–89. https://doi.org/10.1016/j.idc.2019.07.001.

Reis PO, Iser BPM, Oliveira Souza LR, Carvalho Yokota RT, Almeida WAF, Bernal RTI, et al. Monitoring of influenza syndrome in adults in the capitals of Brazil and the Federal district by telephone survey. Rev Bras Epidemiol. 2011;14:115–24. Available:https://doi.org/10.1590/S1415-790X2011000500012

Team NS-OIA (H1N1) VI. Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans. N Engl J Med. 2009;360:2605–15. Available:https://doi.org/10.1056/NOMoa0903810.

Reed C, Angle FJ, Swerdlow DL, Lipsitch M, Meltzer MI, Jernigan D, et al. Estimates of the prevalence of pandemic (H1N1) 2009, United States, April–July 2009. Emerg Infect Dec. 2009;15:2004–7. Available:https://doi.org/10.3201/eid1512.091413.

Madabhavi I, Sarkar M, Kadakol N. COVID-19 a review. Monaldi Arch Chest Dis. 2020;90. Available:https://doi.org/10.4081/monaldi.2020.1298.

Candelli M, Pignataro G, Torelli E, Gulli A, Nista EC, Petrucci M, et al. Effect of influenza vaccine on COVID-19 mortality: A retrospective study. Internal Emerg Med. 2021;16:1849–55. Available:https://doi.org/10.1007/S11739-021-02702-2/TABLES/5

Arokiaraj MC. Correlation of influenza vaccination and influenza incidence on COVID-19 severity and other perspectives. SSRN Electron J; 2020. Available:https://doi.org/10.2139/SSRN.3572814

Fink G, et al. Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil. BMJ Evidence-Based Med. 2021;26:192–3. Available:https://doi.org/10.1136/BMJEBM-2020-111549

Pan American Health Organization (PAHO). PAHO/WHO Brazil - Fact sheet – COVID-19 (disease caused by the new coronavirus). OPAS Bras; 2020. Available:https://www.paho.org/bra/index.php?option=com_content&view=article&id=6101:covid19&Itemid=875

Access on August 9, 2020

Brazil M da S. Special epidemiological bulletin SE 32. 26th ed. Brasilia; 2020.

Para G do E do. COVID-19 Monitoring 09-19-2020. PRODEPA; 2020. Available:https://www.covid-19.pa.gov.br/#/

Access on September 19, 2020

Brazil M da S. Coronavirus Brazil; 2021. Available:https://covid.saude.gov.br/

Access on March 6, 2021

Para G do E do. COVID-19 monitoring. Prodepa – Pará; 2021. Available:https://www.covid-19.pa.gov.br/#/

Access on March 6, 2021

Entwisle B, Stern PC, Environment NRC (US) P on NR on P and the population and environment in Amazonia: Landscape and Household Dynamics; 2005.

Viana RL, Freitas CM de, Giatti LL. Environmental health and development in the legal Amazon: Socioeconomic, environmental and health indicators, challenges and perspectives. Saúde e Soc. 2016;25:233–46. Available:https://doi.org/10.1590/S0104-12902016140843

Gomes BLC, Malato AMP, Ribeiro I do N, et al. Temporal analysis of mercury exposure in the riverside population of the Amazon: an integrative review. Rev Eletrônica Acervo Saúde 2021;13:e7172. Available:https://doi.org/10.25248/reas.e7172.2021.

Brasil M da S. Bemvindo - Open Data; 2021. Available:https://opendatasus.saude.gov.br

Access on September 18, 2021

Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration. Plos Med. 2007;4:e297. Available:https://doi.org/10.1371/journal.pmed.0040297

Brasil M da S. SIVEP-GRIPE; 2021. Available:https://sivepgripe.saude.gov.br/sivepgripe/login.html;jsessionid=Hb2QyO7PsJob7vY5wYZMuA__.server-sivepgripe-srvjpdf217?0

Access on September 18, 2021

Ministry of Health (BR). Genomic surveillance of the SARS-CoV-2 virus within the framework of SVS/MS [electronic resource] / Ministry of Health, Health Surveillance Secretariat. Secr Health Surveillance. 2021:1–52. Available:https://www.gov.br/saude/pt-br/coronavirus/publicacoes-tecnicas/guias-e-planos/vigilancia-genomica-do-virus-sars-cov-2

Access on October 8, 2021

Brazil M da S. SIVEP-GRIPE notification form. OpenDataSUS. 2020:1–2. Available:https://opendatasus.saude.gov.br/dataset/ae90fa8f-3e94-467e-a33f-94adbb66edf8/resource/54a46c6d-e0b5-40b7-8b74-85450d22ace3/download/ficha-srag-final-27.07.2020_final.pdf

Access on August 27, 2021

Brasil M da S. Epidemiological surveillance guide Public health emergency of national importance due to the 2019 coronavirus disease – covid-19. Secr Health Surveillance; 2021. Available:https://ameci.org.br/guia-de-vigilancia-epidemiologica-covid-19/

Access on April 8, 2021

Brasil M da S. Portal of the Secretariat of Primary Health Care. Secr Primary Health Care; 2022. Available:https://aps.saude.gov.br/biblioteca/index

Access on January 22, 2022

Fiocruz IOC. Summary of the InfoGripe Bulletin -- Epidemiological Week (SE) 06 2021. InfoGripe; 2021.

Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020;55:105924. Available:https://doi.org/10.1016/j.ijantimicag.2020.105924

Silva AP de SC, Maia LT de S, Souza WV de. Severe acute respiratory syndrome in pernambuco: Comparison of patterns before and during the COVID-19 pandemic. Cien Saude Colet. 2020;25: 4141–50. Available:https://doi.org/10.1590/1413-812320202510.2.29452020

Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med. 2020;382:2372–4. Available:https://doi.org/10.1056/NEJMc2010419

Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 2020;11:29. Available:https://doi.org/10.1186/s13293-020-00304-9

Zhu J, Ji P, Pang J, Zhong Z, Li H, He C, et al. Clinical characteristics of 3062 COVID-19 patients: A meta-analysis. J Med Virol; 2020. Available:https://doi.org/10.1002/jmv.25884

Li L, Huang T, Wang Y, Wang Z, Liang Y, Huang T, et al. COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020;92:577–83. Available:https://doi.org/10.1002/jmv.25757.

Nikolich-Zugich J, Knox KS, Rios CT, Natt B, Bhattacharya D, Fain MJ. SARS-CoV-2 and COVID-19 in older adults: What we may expect regarding pathogenesis, immune responses, and outcomes. GeroScience. 2020;42:505–14. Available:https://doi.org/10.1007/s11357-020-00186-0

Ambrosino I, Barbagelata E, Ortona E, Ruggieri A, Massiah G, Giannico OV, et al. Gender differences in patients with COVID-19: A narrative review. Monaldi Arch Chest Dis Torace. 2020;90. Available:https://doi.org/10.4081/monaldi.2020.1389.

Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J Infect. 2020;80:656–65. Available:https://doi.org/10.1016/j.jinf.2020.03.041

Dreher M, Kersten A, Bickenbach J, Balfanz P, Hartmann B, Cornelissen C, et al. The characteristics of 50 hospitalized COVID-19 patients with and without ARDS. Dtsch Aerzteblatt Online; 2020. Available:https://doi.org/10.3238/arztebl.2020.0271

Yadaw AS, Li YC, Bose S, Iyengar R, Bunyavanich S, Pandey G. Clinical predictors of COVID-19 mortality. MedRxiv Prepr Serv Heal Sci; 2020. Available:https://doi.org/10.1101/2020.05.19.20103036.

Abu-Raya B. Predictors of refractory coronavirus disease (COVID-19) pneumonia. Clin Infect Dis. 2020;71:895–6. Available:https://doi.org/10.1093/cid/ciaa409

Aly MH, Rahman SS, Ahmed WA, Alghamedi MH, et al. Indicators of critical illness and predictors of mortality in COVID-19 patients. Infect Drug Resist. 2020;13: 1995–2000. Available:https://doi.org/10.2147/IDR.S261159

Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med; 2020. Available:https://doi.org/10.1007/s00134-020-05991-x

Du RH, Liang LR, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J. 2020;55:2000524. Available:https://doi.org/10.1183/13993003.00524-2020

Tian W, Jiang W, et al. Predictors of mortality in hospitalized COVID‐19 patients: A systematic review and meta‐analysis. J Med Virol. 2020;92:1875–83. Available:https://doi.org/10.1002/jmv.26050.

Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020; 94:91–5. Available:https://doi.org/10.1016/j.ijid.2020.03.017

Lucena TMC de, Santos AF da S, Lima BR de, Borborema MEA, Silva J de A. Mechanism of inflammatory response in associated comorbidities in COVID-19. Diabetes Metab Syndr Clin Res Rev. 2020;14:597–600. Available:https://doi.org/10.1016/j.dsx.2020.05.025

Lippi G, Henry BM. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19). Respir Med. 2020;167:105941. Available:https://doi.org/10.1016/j.rmed.2020.105941.

Gao Y, Chen Y, Liu M, Shi S, Tian J. Impacts of immunosuppression and immunodeficiency on COVID-19: A systematic review and meta-analysis. J Infect. 2020;81:e93–5. Available:https://doi.org/10.1016/j.jinf.2020.05.017.

Babaha F, Rezaei N. Primary immunodeficiency diseases in COVID-19 pandemic: A predisposing or protective factor? Am J Med Sci. 2020;360:740–1. Available:https://doi.org/10.1016/j.amjms.2020.07.027

Chhiba KD, Patel GB, Vu THT, Chen MM, et al. Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19. J Allergy Clin Immunol 2020;146:307-314.e4. Available:https://doi.org/10.1016/j.jaci.2020.06.010.

Terry PD, Heidel RE, Dhand R. Asthma in adult patients with COVID-19. Prevalence and risk of severe disease. Am J Respir Crit Care Med. 2021;203:893–905. Available:https://doi.org/10.1164/rccm.202008-3266OC

Marín‐Hernández D, Schwartz RE, Nixon DF. Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID‐19 deaths in Italy. J Med Virol. 2020;93:64–5. Available:https://doi.org/10.1002/jmv.26120

Yang MJ, Rooks BJ, Le TTT, Santiago IO, Diamond J, Dorsey NL, et al. Influenza vaccination and hospitalizations among COVID-19 infected adults. J Am Board Fam Med. 2021;34:S179–82. Available:https://doi.org/10.3122/jabfm.2021.S1.200528

Sardinha DM, Lobato D da C, et al. Analysis of 472,688 severe cases of COVID-19 in Brazil showed lower mortality in those vaccinated against influenza. World J Vaccines. 2021;11:28–32. Available:https://doi.org/10.4236/WJV.2021.113004.

Ñamendys-Silva SA, Alvarado-Ávila PE, Domínguez-Cherit G, Rivero-Sigarroa E, Sánchez-Hurtado LA, Gutiérrez-Villaseñor A, et al. Outcomes of patients with COVID-19 in the intensive care unit in Mexico: A multicenter observational study. Hear Lung. 2020;50:28–32. Available:https://doi.org/10.1016/j.hrtlng.2020.10.013

Marcolino MS, Ziegelmann PK, Souza-Silva MVR, Nascimento IJB, Oliveira LM, Monteiro LS, et al. Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: Results from the Brazilian COVID-19 registry. Int J Infect Dis. 2021;107:300–10. Available:https://doi.org/10.1016/j.ijid.2021.01.019

Marcolino MS, Pires MC, Ramos LEF, et al. ABC2-SPH risk score for in-hospital mortality in COVID-19 patients: Development, external validation and comparison with other available scores. Int J Infect Dis. 2021;110:281–308. Available:https://doi.org/10.1016/j.ijid.2021.07.049

Brasil M da S. Resolution No. 510, of April 07, 2016. Cons Nac Saúde; 2016. Available:http://conselho.saude.gov.br/resolucoes/2016/Reso510.pdf

Access on September 18, 2021

Brazil M of J. Law No. 12,527, of November 18, 2011. Diário Of Da União – DOU; 2011. Available:http://www.planalto.gov.br/ccivil_03/_ato2011-2014/2011/lei/l12527.html

Access on July 25, 2020